Skip to main content
. Author manuscript; available in PMC: 2019 Aug 3.
Published in final edited form as: Contemp Clin Trials. 2018 Sep 12;73:98–110. doi: 10.1016/j.cct.2018.09.004

Table 1.

Demographics of adult patient population in Geisinger nephrology practices

Practice
Name
Total CKD
Patients*
eGFR
< 30
White African
American
Hispanic Female Age >
65
years
Pilot Site** 1754 593 98% 2% 0% 51% 69%
Study Site 1 132 51 99% 2% 0% 58% 74%
Study Site 2 126 50 95% 4% 0% 64% 71%
Study Site 3 861 248 99% 1% 0% 62% 82%
Study Site 4 172 54 98% 1% 0% 53% 81%
Study Site 5 221 58 100% 0% 0% 62% 82%
Study Site 6 582 112 97% 2% 0% 56% 79%
Study Site 7 116 46 99% 1% 0% 51% 82%
Study Site 8 76 34 100% 0% 0% 66% 82%
Grand Total 4,040 1246 98% 2% 0% 56% 76%
*

All patients >18 years with 2 eGFR measures <60 ml/min/1.73m2 more than 90 days apart, not on dialysis, with at least 1 visit at each respective study site;

**

One Geisinger nephrology clinic served only as Pre-Trial Intervention Refinement Site